2-Methylpiperazine, (R)- → 2-[5-Chloro-6-[(3R)-3-methyl-piperazin-1-yl]-pyridin-3-yl]-propan-2-ol
반응식
[Cl:1][C:2]1[CH:3]=[C:4]([C:9]([OH:12])([CH3:11])[CH3:10])[CH:5]=[N:6][C:7]=1Cl.[CH3:13][C@@H:14]1[CH2:19][NH:18][CH2:17][CH2:16][NH:15]1>>[Cl:1][C:2]1[CH:3]=[C:4]([C:9]([OH:12])([CH3:11])[CH3:10])[CH:5]=[N:6][C:7]=1[N:18]1[CH2:17][CH2:16][NH:15][C@H:14]([CH3:13])[CH2:19]1참가 물질
3
실험 절차
A mixture of 2-(5,6-dichloro-pyridin-3-yl)-propan-2-ol from step (b) above (140 mg, 0.68 mmol) and (R)-(−)-2-methyl-piperazine (75 mg, 0.75 mmol, Aldrich) reacted under the conditions of Example 3a to give the title compound. MS (ESI, pos. ion) m/z: 270 (M+1).
후처리
- customreacted under the conditions of Example 3a
출처 및 근거
- ORD 기록
- ord-529ece17452f45229c39f020665a5fdd
- 출처 데이터셋
- uspto-grants-2009_09
- 특허 번호
- US07582761B2
반응 노트
불러오는 중…